You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 9, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
Jerry Leung1,2,3,4, Colton Strong1,2,3, Katherine E Badior5
1Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
Researchers developed a novel method using messenger RNA-lipid nanoparticles (mRNA-LNP) to genetically modify donor platelets. This breakthrough enables platelets to express therapeutic proteins, enhancing their potential as cell therapies for various conditions.
08:29Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: